<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">34842710</PMID>
      <DateRevised>
        <Year>2021</Year>
        <Month>12</Month>
        <Day>03</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2310-2861</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>7</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Nov</Month>
              <Day>18</Day>
            </PubDate>
          </JournalIssue>
          <Title>Gels (Basel, Switzerland)</Title>
          <ISOAbbreviation>Gels</ISOAbbreviation>
        </Journal>
        <ArticleTitle>In Silico Drug Screening Based Development of Novel Formulations for Onychomycosis Management.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">221</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/gels7040221</ELocationID>
        <Abstract>
          <AbstractText>Onychomycosis is a prominent fungal infection that causes discoloration, thickening, and mutilation leading to the separation of the nail from the nail bed. Treatment modalities for onychomycosis may include oral, topical, or combination therapy with antifungals and at times may require chemical or surgical intervention. The burden of side effects of antifungals is enormous, and therefore using molecular docking-based drug selection in context with the target keratin protein would ensure better disease management. Ciclopirox, Amorolfine HCl, Efinaconazole, Tioconazole, and Tavaborole were submitted for assessment, revealing that Amorolfine HCl is the best fit. Consequently, two formulations (Nail lacquer and nanoemulgel) were developed from Amorolfine HCl to validate the in silico screening outcomes. The formulations were further fortified with over-the-counter ingredients vis-a-vis with vitamin E in nail lacquer and undecylenic acid in nanoemulgel for their prominent roles in improving nail health. Both the formulations were systematically designed, optimized, and characterized. Amorolfine HCl containing nanoemulgel (NEG) was developed using undecylenic acid as an oil phase and thioglycolic acid as a penetration enhancer. The quality parameters evaluated were particle size, the zeta potential for nanoemulsion (NE) (78.04 ± 4.724 nm and -0.7mV, respectively), in vitro cumulative drug release (96.74% for NE and 88.54% for NEG), and transungual permeation (about 73.49% for NEG and 54.81% for NE). Nail lacquer was evaluated for the drying time, non-volatile content, and blush test. In vitro cumulative drug release of the developed nail lacquer and comparator marketed formulations were around 81.5% and 75%, respectively. Similarly, the transungual drug permeation was 6.32 μg/cm<sup>2</sup> and 5.89 μg/cm<sup>2</sup>, respectively, in 24 h. The in silico guided preparation of both formulations containing Amorolfine HCl and over the counter ingredients is amenable for therapeutic use against onychomycosis and will be evaluated in the in vivo model.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Fatima</LastName>
            <ForeName>Mahak</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Monawwar</LastName>
            <ForeName>Sadia</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0002-5523-5478</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mohapatra</LastName>
            <ForeName>Sradhanjali</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0002-2124-8537</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alex</LastName>
            <ForeName>Thomson Santosh</ForeName>
            <Initials>TS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ahmed</LastName>
            <ForeName>Abdulrahman</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Taleuzzaman</LastName>
            <ForeName>Mohamad</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0002-5201-3503</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Maulana Azad University, Village Bujhawar, Tehsil Luni, Jodhpur 342802, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ali</LastName>
            <ForeName>Asgar</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ansari</LastName>
            <ForeName>Mohammad Javed</ForeName>
            <Initials>MJ</Initials>
            <Identifier Source="ORCID">0000-0001-9266-7133</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-kharj 16278, Saudi Arabia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mirza</LastName>
            <ForeName>Mohd Aamir</ForeName>
            <Initials>MA</Initials>
            <Identifier Source="ORCID">0000-0002-5780-7601</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Iqbal</LastName>
            <ForeName>Zeenat</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Gels</MedlineTA>
        <NlmUniqueID>101696925</NlmUniqueID>
        <ISSNLinking>2310-2861</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Box–Behnken design</Keyword>
        <Keyword MajorTopicYN="N">amorolfine HCl</Keyword>
        <Keyword MajorTopicYN="N">nail lacquer</Keyword>
        <Keyword MajorTopicYN="N">nanoemulgel</Keyword>
        <Keyword MajorTopicYN="N">transungual permeation</Keyword>
        <Keyword MajorTopicYN="N">undecylenic acid</Keyword>
        <Keyword MajorTopicYN="N">vitamin E</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>29</Day>
          <Hour>12</Hour>
          <Minute>30</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34842710</ArticleId>
        <ArticleId IdType="pmc">PMC8628710</ArticleId>
        <ArticleId IdType="doi">10.3390/gels7040221</ArticleId>
        <ArticleId IdType="pii">gels7040221</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Vlahovic T.C. Onychomycosis: Evaluation, Treatment Options, Managing Recurrence, and Patient Outcomes. Clin. Podiatr. Med. Surg. 2016;33:305–318. doi: 10.1016/j.cpm.2016.02.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cpm.2016.02.001</ArticleId>
            <ArticleId IdType="pubmed">27215153</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gupta A.K., Stec N. Recent Advances in Therapies for Onychomycosis and Its Management. F1000Research. 2019;8:968. doi: 10.12688/f1000research.18646.1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.12688/f1000research.18646.1</ArticleId>
            <ArticleId IdType="pmc">PMC6600855</ArticleId>
            <ArticleId IdType="pubmed">31297182</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mohapatra S., Iqbal Z., Ahmad S., Kohli K., Farooq U., Padhi S., Kabir M., Panda A.K. Menopausal Remediation and Quality of Life (QoL) Improvement: Insights and Perspectives. Endocr. Metab. Immune Disord. Drug Targets. 2020;20:1624–1636. doi: 10.2174/1871530320666200730225830.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/1871530320666200730225830</ArticleId>
            <ArticleId IdType="pubmed">32744978</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cathcart S., Cantrell W., Elewski B.E. Onychomycosis and Diabetes. J. Eur. Acad. Dermatol. Venereol. 2009;23:1119–1122. doi: 10.1111/j.1468-3083.2009.03225.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1468-3083.2009.03225.x</ArticleId>
            <ArticleId IdType="pubmed">19309423</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Christenson J.K., Peterson G.M., Naunton M., Bushell M., Kosari S., Baby K.E., Thomas J. Challenges and Opportunities in the Management of Onychomycosis. J. Fungi. 2018;4:87.  doi: 10.3390/jof4030087.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/jof4030087</ArticleId>
            <ArticleId IdType="pmc">PMC6162761</ArticleId>
            <ArticleId IdType="pubmed">30042327</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lipner S.R., Scher R.K. Onychomycosis: Treatment and Prevention of Recurrence. J. Am. Acad. Dermatol. 2019;80:853–867. doi: 10.1016/j.jaad.2018.05.1260.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaad.2018.05.1260</ArticleId>
            <ArticleId IdType="pubmed">29959962</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elewski B.E., Rich P., Pollak R., Pariser D.M., Watanabe S., Senda H., Ieda C., Smith K., Pillai R., Ramakrishna T., et al.  Efinaconazole 10% Solution in the Treatment of Toenail Onychomycosis: Two Phase III Multicenter, Randomized, Double-Blind Studies. J. Am. Acad. Dermatol. 2013;68:600–608. doi: 10.1016/j.jaad.2012.10.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaad.2012.10.013</ArticleId>
            <ArticleId IdType="pubmed">23177180</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bseiso E.A., Nasr M., Sammour O.A., Abd El Gawad N.A. Novel Nail Penetration Enhancer Containing Vesicles “NPEVs” for Treatment of Onychomycosis. Drug Deliv. 2016;23:2813–2819. doi: 10.3109/10717544.2015.1099059.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/10717544.2015.1099059</ArticleId>
            <ArticleId IdType="pubmed">26447337</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gupta A.K., Stec N., Summerbell R.C., Shear N.H., Piguet V., Tosti A., Piraccini B.M. Onychomycosis: A Review. J. Eur. Acad. Dermatol. Venereol. 2020;34:1972–1990. doi: 10.1111/jdv.16394.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jdv.16394</ArticleId>
            <ArticleId IdType="pubmed">32239567</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dhamoon R.K., Popli H., Gupta M. Novel Drug Delivery Strategies for the Treatment of Onychomycosis. Pharm. Nanotechnol. 2019;7:24–38. doi: 10.2174/2211738507666190228104031.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/2211738507666190228104031</ArticleId>
            <ArticleId IdType="pmc">PMC6691844</ArticleId>
            <ArticleId IdType="pubmed">31092174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jain P., Taleuzzaman M., Kala C., Kumar Gupta D., Ali A., Aslam M. Quality by Design (Qbd) Assisted Development of Phytosomal Gel of Aloe Vera Extract for Topical Delivery. J. Liposome Res. 2020;31:381–388. doi: 10.1080/08982104.2020.1849279.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/08982104.2020.1849279</ArticleId>
            <ArticleId IdType="pubmed">33183121</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Basha B.N., Prakasam K., Goli D. Formulation and Evaluation of Gel Containing Fluconazole-Antifungal Agent. Int. J. Drug Dev. Res. 2011;3:119–127.</Citation>
        </Reference>
        <Reference>
          <Citation>Ferreira S.L.C., Bruns R.E., Ferreira H.S., Matos G.D., David J.M., Brandão G.C., da Silva E.G.P., Portugal L.A., dos Reis P.S., Souza A.S., et al.  Box-Behnken Design: An Alternative for the Optimization of Analytical Methods. Anal. Chim. Acta. 2007;597:179–186. doi: 10.1016/j.aca.2007.07.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.aca.2007.07.011</ArticleId>
            <ArticleId IdType="pubmed">17683728</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Satpathi P., Banerjee D., Maiti A., Sengupta M., Mohata A. Onychomycosis in Eastern India -Study in a Peripheral Tertiary Care Centre. J. Pak. Assoc. Dermatol. 2013;23:14–19.</Citation>
        </Reference>
        <Reference>
          <Citation>Alessandrini A., Starace M., Bruni F., Piraccini B.M. An Open Study to Evaluate Effectiveness and Tolerability of a Nail Oil Composed of Vitamin E and Essential Oils in Mild to Moderate Distal Subungual Onychomycosis. Ski. Appendage Disord. 2020;6:14–18. doi: 10.1159/000503305.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000503305</ArticleId>
            <ArticleId IdType="pmc">PMC6995982</ArticleId>
            <ArticleId IdType="pubmed">32021856</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petrović M., Bonvin D., Hofmann H., Mionić Ebersold M. Fungicidal PMMA-Undecylenic Acid Composites. Int. J. Mol. Sci. 2018;19:184.  doi: 10.3390/ijms19010184.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms19010184</ArticleId>
            <ArticleId IdType="pmc">PMC5796133</ArticleId>
            <ArticleId IdType="pubmed">29316713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bellet J.S., Daniel C.R.  Home remedies for onychomycosis. In: Rigopoulos D., Elewski B., Richert B., editors. Onychomycosis. John Wiley &amp; Sons; Chichester, UK: 2018. pp. 207–212.</Citation>
        </Reference>
        <Reference>
          <Citation>Van der Steen M., Stevens C.V. Undecylenic Acid: A Valuable and Physiologically Active Renewable Building Block from Castor Oil. ChemSusChem. 2009;2:692–713. doi: 10.1002/cssc.200900075.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cssc.200900075</ArticleId>
            <ArticleId IdType="pubmed">19650106</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rehder P., Nguyen T.T. A New Concept in the Topical Treatment of Onychomycosis with Cyanoacrylate, Undecylenic Acid, and Hydroquinone. Foot Ankle Spec. 2008;1:93–96. doi: 10.1177/1938640008315350.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1938640008315350</ArticleId>
            <ArticleId IdType="pubmed">19825699</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aswathanarayan J.B., Vittal R.R. Nanoemulsions and Their Potential Applications in Food Industry. Front. Sustain. Food Syst. 2019;3:95. doi: 10.3389/fsufs.2019.00095.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fsufs.2019.00095</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luan J., Zheng F., Yang X., Yu A., Zhai G. Nanostructured Lipid Carriers for Oral Delivery of Baicalin: In Vitro and In Vivo Evaluation. Colloids Surf. Physicochem. Eng. Asp. 2015;466:154–159. doi: 10.1016/j.colsurfa.2014.11.015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.colsurfa.2014.11.015</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar G.P., Rajeshwarrao P. Nonionic Surfactant Vesicular Systems for Effective Drug Delivery—An Overview. Acta Pharm. Sin. B. 2011;1:208–219. doi: 10.1016/j.apsb.2011.09.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.apsb.2011.09.002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Atrux-Tallau N., Lasselin J., Han S.-H., Delmas T., Bibette J. Quantitative Analysis of Ligand Effects on Bioefficacy of Nanoemulsion Encapsulating Depigmenting Active. Colloids Surf. B Biointerfaces. 2014;122:390–395. doi: 10.1016/j.colsurfb.2014.07.021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.colsurfb.2014.07.021</ArticleId>
            <ArticleId IdType="pubmed">25087020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mahtab A., Anwar M., Mallick N., Naz Z., Jain G.K., Ahmad F.J. Transungual Delivery of Ketoconazole Nanoemulgel for the Effective Management of Onychomycosis. AAPS PharmSciTech. 2016;17:1477–1490. doi: 10.1208/s12249-016-0488-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1208/s12249-016-0488-0</ArticleId>
            <ArticleId IdType="pubmed">26857516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaur R., Sharma N., Tikoo K., Sinha V.R. Development of Mirtazapine Loaded Solid Lipid Nanoparticles for Topical Delivery: Optimization, Characterization and Cytotoxicity Evaluation. Int. J. Pharm. 2020;586:119439. doi: 10.1016/j.ijpharm.2020.119439.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijpharm.2020.119439</ArticleId>
            <ArticleId IdType="pubmed">32622808</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lokhandwala H., Deshpande A., Deshpande S. Kinetic modeling and dissolution profiles comparison: An overview. Int. J. Pharm. Bio. Sci. 2013;10:728–773.</Citation>
        </Reference>
        <Reference>
          <Citation>Bhuptani R.S., Deshpande K.M., Patravale V.B. Transungual Permeation: Current Insights. Drug Deliv. Transl. Res. 2016;6:426–439. doi: 10.1007/s13346-015-0259-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s13346-015-0259-6</ArticleId>
            <ArticleId IdType="pubmed">26419676</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akhtar J., Khan A.A., Ali Z., Haider R., Shahar Yar M. Structure-Activity Relationship (SAR) Study and Design Strategies of Nitrogen-Containing Heterocyclic Moieties for Their Anticancer Activities. Eur. J. Med. Chem. 2017;125:143–189. doi: 10.1016/j.ejmech.2016.09.023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejmech.2016.09.023</ArticleId>
            <ArticleId IdType="pubmed">27662031</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Molecular Modeling, Synthesis, and Evaluation of 1-(4-Methoxybenzofuran-5-Yl)-3-Phenylpropane-1, 3-Dione for Its Anxiolytic Potentiality.  [(accessed on 11 September 2021)].  Available online:  https://scholar.google.com/citations?view_op=view_citation&amp;hl=en&amp;user=EsG-lKYAAAAJ&amp;citation_for_view=EsG-lKYAAAAJ:2osOgNQ5qMEC.</Citation>
        </Reference>
        <Reference>
          <Citation>Haider M.R., Ahmad K., Siddiqui N., Ali Z., Akhtar M.J., Fuloria N., Fuloria S., Ravichandran M., Yar M.S. Novel 9-(2-(1-Arylethylidene)Hydrazinyl)Acridine Derivatives: Target Topoisomerase 1 and Growth Inhibition of HeLa Cancer Cells. Bioorganic Chem. 2019;88:102962. doi: 10.1016/j.bioorg.2019.102962.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bioorg.2019.102962</ArticleId>
            <ArticleId IdType="pubmed">31085373</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Al P.A.K. et Antipsychotic Potential and Molecular Modelling of 1-(4-Methoxybenzofuran-5-Yl)-3-Phenylpropane-1, 3-Dione. J. Gujarat Res. Soc. 2019;21:362–369.</Citation>
        </Reference>
        <Reference>
          <Citation>Kerai L.V., Hilton S., Murdan S. UV-Curable Gel Formulations: Potential Drug Carriers for the Topical Treatment of Nail Diseases. Int. J. Pharm. 2015;492:177–190. doi: 10.1016/j.ijpharm.2015.07.020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijpharm.2015.07.020</ArticleId>
            <ArticleId IdType="pubmed">26187167</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Šveikauskaitė I., Pockevičius A., Briedis V. Potential of Chemical and Physical Enhancers for Transungual Delivery of Amorolfine Hydrochloride. Materials. 2019;12:1028.  doi: 10.3390/ma12071028.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ma12071028</ArticleId>
            <ArticleId IdType="pmc">PMC6480142</ArticleId>
            <ArticleId IdType="pubmed">30925734</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tran T.T.D., Tran P.H.L. Controlled Release Film Forming Systems in Drug Delivery: The Potential for Efficient Drug Delivery. Pharmaceutics. 2019;11:290.  doi: 10.3390/pharmaceutics11060290.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/pharmaceutics11060290</ArticleId>
            <ArticleId IdType="pmc">PMC6630634</ArticleId>
            <ArticleId IdType="pubmed">31226748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Verma D., Thakur P.S., Padhi S., Khuroo T., Talegaonkar S., Iqbal Z. Design Expert Assisted Nanoformulation Design for Co-Delivery of Topotecan and Thymoquinone: Optimization, in Vitro Characterization and Stability Assessment. J. Mol. Liq. 2017;242:382–394. doi: 10.1016/j.molliq.2017.07.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molliq.2017.07.002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>PubMed  Application of Response Surface Methodology for Design and Optimization of Reservoir-Type Transdermal Patch of Simvastatin.  [(accessed on 11 September 2021)]; Available online:  https://pubmed.ncbi.nlm.nih.gov/26452533/</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26452533</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akhtar N., Sharma H., Pathak K. Onychomycosis: Potential of Nail Lacquers in Transungual Delivery of Antifungals. Scientifica. 2016;2016:1387936. doi: 10.1155/2016/1387936.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2016/1387936</ArticleId>
            <ArticleId IdType="pmc">PMC4829734</ArticleId>
            <ArticleId IdType="pubmed">27123362</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Souza A.M.S., Ribeiro R.C.A., Pinheiro G.K.L.O., Pinheiro F.I., Oliveira W.N., Souza L.B.F.C., Silva A.L., Amaral-Machado L., Alencar É.N., Chaves G.M., et al.  Polishing the Therapy of Onychomycosis Induced by Candida spp.: Amphotericin B-Loaded Nail Lacquer. Pharmaceutics. 2021;13:784.  doi: 10.3390/pharmaceutics13060784.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/pharmaceutics13060784</ArticleId>
            <ArticleId IdType="pmc">PMC8225016</ArticleId>
            <ArticleId IdType="pubmed">34073997</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Joshi M., Sharma V., Pathak K. Matrix Based System of Isotretinoin as Nail Lacquer to Enhance Transungal Delivery across Human Nail Plate. Int. J. Pharm. 2015;478:268–277. doi: 10.1016/j.ijpharm.2014.11.050.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijpharm.2014.11.050</ArticleId>
            <ArticleId IdType="pubmed">25445993</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>ScienceDirect  Efinaconazole Nail Lacquer for the Transungual Drug Delivery: Formulation, Optimization, Characterization and in Vitro Evaluation.  [(accessed on 11 September 2021)].  Available online:  https://www.sciencedirect.com/science/article/abs/pii/S1773224720312879.</Citation>
        </Reference>
        <Reference>
          <Citation>Sigma-Aldrich  Dialysis Tubing Cellulose Membrane Avg. Flat Width 25 Mm (1.0 in.)  [(accessed on 11 September 2021)].  Available online:  http://www.sigmaaldrich.com/</Citation>
        </Reference>
        <Reference>
          <Citation>Hassan N., Singh M., Sulaiman S., Jain P., Sharma K., Nandy S., Dudeja M., Ali A., Iqbal Z. Molecular Docking-Guided Ungual Drug-Delivery Design for Amelioration of Onychomycosis. ACS Omega. 2019;4:9583–9592. doi: 10.1021/acsomega.9b00436.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acsomega.9b00436</ArticleId>
            <ArticleId IdType="pmc">PMC6648890</ArticleId>
            <ArticleId IdType="pubmed">31460049</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hooda A., Sradhanjali M. Popsy Formulation and Evaluation of Novel Solid Lipid Microparticles for the Sustained Release of Ofloxacin. Pharm. Nanotechnol. 2018;5:329–341. doi: 10.2174/2211738506666171226121720.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/2211738506666171226121720</ArticleId>
            <ArticleId IdType="pubmed">29278216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patel M.M., Vora Z.M. Formulation Development and Optimization of Transungual Drug Delivery System of Terbinafine Hydrochloride for the Treatment of Onychomycosis. Drug Deliv. Transl. Res. 2016;6:263–275. doi: 10.1007/s13346-016-0287-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s13346-016-0287-x</ArticleId>
            <ArticleId IdType="pubmed">26926242</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Menon S., Verma D., Khuroo T., Talegaonkar S., Iqbal Z. Extraction of a water soluble bioactive hypoxoside and its development into an ethosomal system for deep dermal delivery. Int. J. Pharm. Pharm. Sci. 2015;7:211–215.</Citation>
        </Reference>
        <Reference>
          <Citation>Patel J., Patel A., Raval M., Sheth N. Formulation and Development of a Self-Nanoemulsifying Drug Delivery System of Irbesartan. J. Adv. Pharm. Technol. Res. 2011;2:9–16. doi: 10.4103/2231-4040.79799.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/2231-4040.79799</ArticleId>
            <ArticleId IdType="pmc">PMC3217686</ArticleId>
            <ArticleId IdType="pubmed">22171286</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Azeem A., Rizwan M., Ahmad F.J., Iqbal Z., Khar R.K., Aqil M., Talegaonkar S. Nanoemulsion Components Screening and Selection: A Technical Note. AAPS PharmSciTech. 2009;10:69–76. doi: 10.1208/s12249-008-9178-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1208/s12249-008-9178-x</ArticleId>
            <ArticleId IdType="pmc">PMC2663668</ArticleId>
            <ArticleId IdType="pubmed">19148761</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mirza M.A., Ahmad S., Mallick M.N., Manzoor N., Talegaonkar S., Iqbal Z. Development of a Novel Synergistic Thermosensitive Gel for Vaginal Candidiasis: An In Vitro, In Vivo Evaluation. Colloids Surf. B Biointerfaces. 2013;103:275–282. doi: 10.1016/j.colsurfb.2012.10.038.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.colsurfb.2012.10.038</ArticleId>
            <ArticleId IdType="pubmed">23201748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chan M.Y., Dowling Q.M., Sivananthan S.J., Kramer R.M. Particle Sizing of Nanoparticle Adjuvant Formulations by Dynamic Light Scattering (DLS) and Nanoparticle Tracking Analysis (NTA) Methods Mol. Biol. 2017;1494:239–252. doi: 10.1007/978-1-4939-6445-1_17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-1-4939-6445-1_17</ArticleId>
            <ArticleId IdType="pubmed">27718198</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaszuba M., Corbett J., Watson F.M., Jones A. High-Concentration Zeta Potential Measurements Using Light-Scattering Techniques. Philos. Trans. A Math. Phys. Eng. Sci. 2010;368:4439–4451. doi: 10.1098/rsta.2010.0175.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1098/rsta.2010.0175</ArticleId>
            <ArticleId IdType="pmc">PMC2981904</ArticleId>
            <ArticleId IdType="pubmed">20732896</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pathan I., Mangle M., Bairagi S. Design and Characterization of Nanoemulsion for Transdermal Delivery of Meloxicam. Anal. Chem. Lett. 2016;6:286–295. doi: 10.1080/22297928.2016.1209126.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/22297928.2016.1209126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mao Y., Chen X., Xu B., Shen Y., Ye Z., Chaurasiya B., Liu L., Li Y., Xing X., Chen D. Eprinomectin Nanoemulgel for Transdermal Delivery against Endoparasites and Ectoparasites: Preparation, In Vitro and In Vivo Evaluation. Drug Deliv. 2019;26:1104–1114. doi: 10.1080/10717544.2019.1682720.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/10717544.2019.1682720</ArticleId>
            <ArticleId IdType="pmc">PMC6882498</ArticleId>
            <ArticleId IdType="pubmed">31735104</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Algahtani M.S., Ahmad M.Z., Ahmad J. Nanoemulgel for Improved Topical Delivery of Retinyl Palmitate: Formulation Design and Stability Evaluation. Nanomaterials. 2020;10:848.  doi: 10.3390/nano10050848.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/nano10050848</ArticleId>
            <ArticleId IdType="pmc">PMC7711631</ArticleId>
            <ArticleId IdType="pubmed">32353979</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taleuzzaman M., Sartaj A., Kumar G.D., Gilani S.J., Mirza M.A. Phytosomal Gel of Manjistha Extract (MJE) Formulated and Optimized with Central Composite Design of Quality by Design (QbD) J. Dispers. Sci. Technol. 2021;42:1–9. doi: 10.1080/01932691.2021.1942036.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/01932691.2021.1942036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khuroo T., Verma D., Khuroo A., Ali A., Iqbal Z. Simultaneous Delivery of Paclitaxel and Erlotinib from Dual Drug Loaded PLGA Nanoparticles: Formulation Development, Thorough Optimization and in Vitro Release. J. Mol. Liq. 2018;257:52–68. doi: 10.1016/j.molliq.2018.02.091.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molliq.2018.02.091</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palliyil B.B., Li C., Owaisat S., Lebo D.B. Lateral Drug Diffusion in Human Nails. AAPS PharmSciTech. 2014;15:1429–1438. doi: 10.1208/s12249-014-0169-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1208/s12249-014-0169-9</ArticleId>
            <ArticleId IdType="pmc">PMC4245422</ArticleId>
            <ArticleId IdType="pubmed">24970585</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
